GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » ROE % Adjusted to Book Value

Deltex Medical Group (LSE:DEMG) ROE % Adjusted to Book Value : -77.77% (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group ROE % Adjusted to Book Value?

Deltex Medical Group's ROE % for the quarter that ended in Dec. 2023 was -56.77%. Deltex Medical Group's PB Ratio for the quarter that ended in Dec. 2023 was 0.73. Deltex Medical Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -77.77%.


Deltex Medical Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Deltex Medical Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group ROE % Adjusted to Book Value Chart

Deltex Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.14 -10.08 -8.48 -15.73 -62.30

Deltex Medical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.65 -19.26 -11.41 -12.46 -77.77

Competitive Comparison of Deltex Medical Group's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Deltex Medical Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deltex Medical Group's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Deltex Medical Group's ROE % Adjusted to Book Value falls into.



Deltex Medical Group ROE % Adjusted to Book Value Calculation

Deltex Medical Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-45.48% / 0.73
=-62.30%

Deltex Medical Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-56.77% / 0.73
=-77.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltex Medical Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltex Medical Group (LSE:DEMG) Business Description

Traded in Other Exchanges
Address
Terminus Road, Chichester, W Sussex, GBR, PO19 8TX
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (LSE:DEMG) Headlines

No Headlines